In the final days of the campaign, stark disagreements between Vice President Kamala Harris and former President Donald Trump over the future of American health care are on display — in particular, in sober warnings about abortion access, the specter of future cuts to the Affordable Care Act, and bold pronouncements about empowering activists eager […]
Several Democratic-led states have expanded public insurance programs to cover immigrants in the U.S. regardless of legal status. Donald Trump is trying to blame Kamala Harris for the policies.
Conservative groups are working to undermine support for Montana’s Medicaid expansion ahead of a political fight over whether to keep the program.
For snakebite victims, antivenom is critical — and costly. It took more than $200,000 worth of antivenom to save one toddler’s life after he was bitten by a rattlesnake.
Medications such as methadone can cut the risk of a fatal opioid overdose in half. Medicaid covers the medication. But as state Medicaid programs reevaluated coverage of each enrollee following a pause in disenrollments during the covid-19 pandemic, some patients lost a crucial pillar of their sobriety.
Nineteen states are seeking to stall a Biden administration rule that would allow recipients of the Deferred Action for Childhood Arrivals program to enroll in ACA coverage and qualify for subsidies. DACA provides work authorization and temporary deportation protection to people brought to the U.S. as children without immigration paperwork.
The United States has made almost no progress in closing racial health disparities despite promises, research shows. The government, some critics argue, is often the underlying culprit.
The outcome of the upcoming presidential election could affect the number of insured Americans, the fate of premium-reducing subsidies, the shape of Medicaid, and the cost of coverage for tens of millions of people.
Health care hasn’t figured prominently on the campaign trail this fall. These voters wish it would.
Every year, Medicare officials encourage beneficiaries to shop around for their drug coverage. Few take the time. This year, it might be more important than ever.
